JP2022506716A5 - - Google Patents
Info
- Publication number
- JP2022506716A5 JP2022506716A5 JP2021524278A JP2021524278A JP2022506716A5 JP 2022506716 A5 JP2022506716 A5 JP 2022506716A5 JP 2021524278 A JP2021524278 A JP 2021524278A JP 2021524278 A JP2021524278 A JP 2021524278A JP 2022506716 A5 JP2022506716 A5 JP 2022506716A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- manp
- approximately
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024111406A JP2024156691A (ja) | 2018-11-09 | 2024-07-11 | 抵抗性高血圧に対する併用療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862758009P | 2018-11-09 | 2018-11-09 | |
| US62/758,009 | 2018-11-09 | ||
| PCT/US2019/060401 WO2020097421A1 (en) | 2018-11-09 | 2019-11-08 | Combination treatment for resistant hypertension |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024111406A Division JP2024156691A (ja) | 2018-11-09 | 2024-07-11 | 抵抗性高血圧に対する併用療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022506716A JP2022506716A (ja) | 2022-01-17 |
| JP2022506716A5 true JP2022506716A5 (https=) | 2022-11-17 |
Family
ID=70612496
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524278A Pending JP2022506716A (ja) | 2018-11-09 | 2019-11-08 | 抵抗性高血圧に対する併用療法 |
| JP2024111406A Pending JP2024156691A (ja) | 2018-11-09 | 2024-07-11 | 抵抗性高血圧に対する併用療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024111406A Pending JP2024156691A (ja) | 2018-11-09 | 2024-07-11 | 抵抗性高血圧に対する併用療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20220118054A1 (https=) |
| EP (2) | EP4603090A1 (https=) |
| JP (2) | JP2022506716A (https=) |
| KR (1) | KR20210090229A (https=) |
| CN (1) | CN113727997A (https=) |
| AU (2) | AU2019375988A1 (https=) |
| BR (1) | BR112021008841A2 (https=) |
| CA (1) | CA3119055A1 (https=) |
| ES (1) | ES3047085T3 (https=) |
| IL (2) | IL282958B2 (https=) |
| MX (1) | MX2021005453A (https=) |
| PL (1) | PL3877402T3 (https=) |
| WO (1) | WO2020097421A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240369535A1 (en) * | 2021-09-07 | 2024-11-07 | Mayo Foundation For Medical Education And Research | METHODS AND MATERIALS FOR DETERMINING pGC TARGET DOSAGE |
| WO2023039453A2 (en) * | 2021-09-09 | 2023-03-16 | Mayo Foundation For Medical Education And Research | Dual-function polypeptides and methods for use thereof |
| US20240116990A1 (en) * | 2022-09-19 | 2024-04-11 | Mayo Foundation For Medical Education And Research | Compositions and Methods of Treatment Using CRRL 191 |
| KR20250150650A (ko) * | 2023-02-22 | 2025-10-20 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | Manp를 이용한 대사증후군을 동반한 고혈압 치료 방법 |
| US12427185B2 (en) | 2023-09-05 | 2025-09-30 | E-Star Biotech, LLC | Formulations of MANP and uses thereof |
| WO2025184377A1 (en) * | 2024-02-28 | 2025-09-04 | Mayo Foundation For Medical Education And Research | Methods for sustained lowering of blood pressure using manp |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4161521A (en) | 1975-08-08 | 1979-07-17 | Merck & Co., Inc. | Somatostatin analogs |
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
| US4757048A (en) | 1985-11-05 | 1988-07-12 | Biotechnology Research Associates J.V. | Synthetic analogs of atrial natriuretic peptides |
| US6312679B1 (en) | 1986-08-18 | 2001-11-06 | The Dow Chemical Company | Dense star polymer conjugates as dyes |
| US4935492A (en) | 1987-12-24 | 1990-06-19 | California Biotechnology Inc. | Cyclic analogs of atrial natriuretic peptides |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| DE4004430A1 (de) | 1990-02-09 | 1991-08-14 | Schering Ag | Aus polyaldehyden aufgebaute kontrastmittel |
| KR930009516B1 (ko) | 1990-04-27 | 1993-10-06 | 미쓰비시덴키 가부시키가이샤 | 진동검출기 및 그의 고유진동주파수 조정방법 |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| US5529914A (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5698213A (en) | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters |
| US6410044B1 (en) | 1998-03-19 | 2002-06-25 | Surmodics, Inc. | Crosslinkable macromers |
| US6969480B2 (en) | 2000-05-12 | 2005-11-29 | Matregen Corp. | Method of producing structures using centrifugal forces |
| WO2004047871A2 (en) | 2002-11-26 | 2004-06-10 | Nobex Corporation | Modified naturetic compounds, conjugates, and uses thereof |
| DE602005013244D1 (de) | 2004-08-12 | 2009-04-23 | Quest Pharmaceutical Services | Pharmazeutische zusammensetzungen für die kontroll |
| WO2008061355A1 (en) | 2006-11-24 | 2008-05-29 | Matregen Corp. | Glp-1 depot systems, and methods of manufacture and uses thereof |
| US20100266704A1 (en) | 2008-12-15 | 2010-10-21 | Novartis Ag | Octreotide depot formulation with constantly high exposure levels |
| WO2015135024A1 (en) * | 2014-03-14 | 2015-09-17 | Madeleine Pharmaceuticals Pty Ltd | Adjuvant therapy to standard of care (soc) diuretic treatment |
| US11072642B2 (en) * | 2016-11-09 | 2021-07-27 | Mayo Foundation For Medical Education And Research | MANP analogues |
-
2019
- 2019-11-08 PL PL19881216.6T patent/PL3877402T3/pl unknown
- 2019-11-08 IL IL282958A patent/IL282958B2/en unknown
- 2019-11-08 ES ES19881216T patent/ES3047085T3/es active Active
- 2019-11-08 CN CN201980088279.4A patent/CN113727997A/zh active Pending
- 2019-11-08 CA CA3119055A patent/CA3119055A1/en active Pending
- 2019-11-08 KR KR1020217017589A patent/KR20210090229A/ko not_active Ceased
- 2019-11-08 US US17/292,083 patent/US20220118054A1/en not_active Abandoned
- 2019-11-08 WO PCT/US2019/060401 patent/WO2020097421A1/en not_active Ceased
- 2019-11-08 BR BR112021008841-5A patent/BR112021008841A2/pt unknown
- 2019-11-08 IL IL315007A patent/IL315007A/en unknown
- 2019-11-08 EP EP25186872.5A patent/EP4603090A1/en active Pending
- 2019-11-08 JP JP2021524278A patent/JP2022506716A/ja active Pending
- 2019-11-08 EP EP19881216.6A patent/EP3877402B1/en active Active
- 2019-11-08 AU AU2019375988A patent/AU2019375988A1/en not_active Abandoned
- 2019-11-08 MX MX2021005453A patent/MX2021005453A/es unknown
-
2024
- 2024-07-11 JP JP2024111406A patent/JP2024156691A/ja active Pending
-
2025
- 2025-04-29 US US19/193,423 patent/US20250381249A1/en active Pending
- 2025-05-16 AU AU2025203575A patent/AU2025203575A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022506716A5 (https=) | ||
| CN110339346B (zh) | 皮肤外用剂组合物 | |
| JP2023088944A5 (https=) | ||
| CN102596216B (zh) | 鼻炎治疗剂 | |
| KR101671406B1 (ko) | 신장 장애 치료용 조성물 및 방법 | |
| JP2018512454A5 (https=) | ||
| JP2019214610A (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| RU2016110153A (ru) | Новые пептиды и их аналоги для применения при лечении мукозита полости рта | |
| CN101325964B (zh) | Vip片段和应用方法 | |
| JP2023123440A (ja) | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 | |
| JP2023503380A5 (https=) | ||
| JPH072698A (ja) | 全身的炎症応答症候群の病的結果を治療するための薬剤組成物 | |
| MX2011010341A (es) | Composiciones y metodos para el tratamiento de fibrosis aortica. | |
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| KR101656324B1 (ko) | 키닌 ｂ２ 수용체 길항제 및 코르티코스테로이드에 기반한 약학적 조성물 및 그의 용도 | |
| JP2021518392A5 (https=) | ||
| CN113318222A (zh) | 超氧化物歧化酶在制备治疗银屑病药物中的应用及方法 | |
| RU2013103487A (ru) | Вакцинотерапия неоваскуляризации сосудистой оболочки глаза | |
| JP3588472B2 (ja) | 急性膵炎治療用ブラジキニン拮抗剤 | |
| WO1994022462A1 (fr) | Complexe immunomodulateur anti-sida | |
| JP2025503607A5 (https=) | ||
| US11090290B2 (en) | Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy | |
| JP2024517025A (ja) | 乾癬の治療のための方法 | |
| HK40039808A (en) | Angiotensin ii alone or in combination for the treatment of hypotension | |
| JP2688733B2 (ja) | 消化管粘膜障害の予防及び治療剤 |